Immunogenetic Relationship of HLA-G 14 bp Insertion/Deletion Polymorphism and Toll-Like Receptor 9 with Systemic Lupus Erythematosus in Egyptian Patients: A Case-Control Study

References

• Chen L, Wang YF, Liu L, et al. Genome-wide assessment of genetic risk for systemic lupus erythematosus and disease severity. Hum Mol Genet. 2020;29(10):1745–1756. doi:10.1093/hmg/ddaa030
   PubMed Web of Science ®Google Scholar
• Barbhaiya M, Costenbader KH. Environmental exposures and the development of systemic lupus erythematosus. Curr Opin Rheumatol. 2016;28(5):497–505. doi:10.1097/BOR.0000000000000318
   PubMed Web of Science ®Google Scholar
• Wang YF, Zhang Y, Lin Z, et al. Identification of 38 novel loci for systemic lupus erythematosus and genetic heterogeneity between ancestral groups. Nat Commun. 2021;12(1):772. doi:10.1038/s41467-021-21049-y
   PubMed Web of Science ®Google Scholar
• Attia DH, Dorgham DA, El Maghraby AA, et al. Autoimmune regulator gene polymorphisms in Egyptian systemic lupus erythematosus patients: preliminary results. Int J Rheumatol. 2021;2021(28):5546639. doi:10.1155/2021/5546639
   PubMedGoogle Scholar
• Zedan MM, Attia ZR, Abd El Azeem RA, Mutawi TM, El Shehawy AS, Bakr A. Genetic polymorphisms in genes involved in the type I interferon system (IFIH1/MDA-5, TNFAIP3/A20, and STAT4): association with SLE risk in Egyptian children and adolescents. J Inflamm Res. 2021;15:3349–3358. doi:10.2147/JIR.S309008
   Web of Science ®Google Scholar
• Ali YBM, El-Akhras BA, El-Shazly R, Bassyouni IH. Genetic polymorphisms of IL-27 and risk of systemic lupus erythematosus disease in the Egyptian population. Clin Rheumatol. 2021;40(12):4899–4907. doi:10.1007/s10067-021-05858-6
   PubMed Web of Science ®Google Scholar
• Abo El-Khair SM, Sameer W, Awadallah N, Shaalan D. Programmed cell death 1 gene polymorphism as a possible risk for systemic lupus erythematosus in Egyptian females. Lupus. 2019;28(12):1427–1434. doi:10.1177/0961203319878493
   PubMed Web of Science ®Google Scholar
• Al-Kholy W, Elsaid A, Sleem A, Fathy H, Elshazli R, Settin A. TNF-α - 308 G > A and IFN-γ + 874 A > T gene polymorphisms in Egyptian patients with lupus erythematosus. Meta Gene. 2016;4(9):137–141. doi:10.1016/j.mgene.2016.06.002
   Google Scholar
• Castelli EC, Ramalho J, Porto IO, et al. Insights into HLA-G genetics provided by worldwide haplotype diversity. Front Immunol. 2014;5:476. doi:10.3389/fimmu.2014.00476
   PubMed Web of Science ®Google Scholar
• Xu X, Zhou Y, Wei H. Roles of HLA-G in the maternal-fetal immune microenvironment. Front Immunol. 2020;22(11):592010. doi:10.3389/fimmu.2020.592010
   Web of Science ®Google Scholar
• Carosella ED, Rouas-Freiss N, Tronik-le Roux D, Moreau P, LeMaoult J. HLA-G: an immune checkpoint molecule. Adv Immunol. 2015;127:33–144. doi:10.1016/bs.ai.2015.04.001
   PubMed Web of Science ®Google Scholar
• Carosella ED, Favier B, Rouas-Freiss N, Moreau P, Lemaoult J. Beyond the increasing complexity of the immunomodulatory HLA-G molecule. Blood. 2008;111(10):4862–4870. doi:10.1182/blood-2007-12-127662
   PubMed Web of Science ®Google Scholar
• Rizzo R, Bortolotti D, Bolzani S, et al. HLA-G molecules in autoimmune diseases and infections. Front Immunol. 2014;5:592. doi:10.3389/fimmu.2014.00592
   PubMed Web of Science ®Google Scholar
• Rizzo R, Hviid TV, Govoni M, et al. HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus. Tissue Antigens. 2008;71(6):520–529. doi:10.1111/j.1399-0039.2008.01037.x
   PubMedGoogle Scholar
• Catamo E, Addobbati C, Segat L, et al. Comprehensive analysis of polymorphisms in the HLA-G 5′ upstream regulatory and 3′ untranslated regions in Brazilian patients with systemic lupus erythematosus. Tissue Antigens. 2015;85(6):458–465. doi:10.1111/tan.12545
   PubMedGoogle Scholar
• Hachiya Y, Kawasaki A, Oka S, et al. Association of HLA-G 3’ untranslated region polymorphisms with systemic lupus erythematosus in a Japanese population: a case-control association study. PLoS One. 2016;11(6):e0158065. doi:10.1371/journal.pone.0158065
   PubMed Web of Science ®Google Scholar
• Rousseau P, Le Discorde M, Mouillot G, Marcou C, Carosella ED, Moreau P. The 14 bp deletion-insertion polymorphism in the 3’ UT region of the HLA-G gene influences HLA-G mRNA stability. Hum Immunol. 2003;64(11):1005–1010. doi:10.1016/j.humimm.2003.08.347
   PubMed Web of Science ®Google Scholar
• Chen XY, Yan WH, Lin A, Xu HH, Zhang JG, Wang XX. The 14 bp deletion polymorphisms in HLA-G gene play an important role in the expression of soluble HLA-G in plasma. Tissue Antigens. 2008;72(4):335–341. doi:10.1111/j.1399-0039.2008.01107.x
   PubMedGoogle Scholar
• Donadi EA, Castelli EC, Arnaiz-Villena A, Roger M, Rey D, Moreau P. Implications of the polymorphism of HLA-G on its function, regulation, evolution, and disease association. Cell Mol Life Sci. 2011;68(3):369–395. doi:10.1007/s00018-010-0580-7
   PubMed Web of Science ®Google Scholar
• Alvarez M, Piedade J, Balseiro S, Ribas G, Regateiro F. HLA-G 3’-UTR SNP and 14-bp deletion polymorphisms in Portuguese and Guinea-Bissau populations. Int J Immunogenet. 2009;36(6):361–366. doi:10.1111/j.1744-313X.2009.00875.x
   PubMed Web of Science ®Google Scholar
• Amodio G, Gregori S. HLA-G genotype/expression/disease association studies: success, hurdles, and perspectives. Front Immunol. 2020;11:1178. doi:10.3389/fimmu.2020.01178
   PubMed Web of Science ®Google Scholar
• Własiuk P, Tomczak W, Zając M, Dmoszyńska A, Giannopoulos K. Total expression of HLA-G and TLR-9 in chronic lymphocytic leukemia patients. Hum Immunol. 2013;74(12):1592–1597. doi:10.1016/j.humimm.2013.08.277
   PubMed Web of Science ®Google Scholar
• Yuan Y, Zhao L, Ye Z, Ma H, Wang X, Jiang Z. Association of Toll‑like receptor 9 expression with prognosis of systemic lupus erythematosus. Exp Ther Med. 2019;17(4):3247–3254. doi:10.3892/etm.2019.7290
   PubMed Web of Science ®Google Scholar
• Rao H, Zeng Q, Liang Y, Xiao C, Xie S, Xu X. Correlation between TLR9 expression and cytokine secretion in the clinical diagnosis of systemic lupus erythematosus. Mediators Inflamm. 2015;2015:710720. doi:10.1155/2015/710720
   PubMed Web of Science ®Google Scholar
• Tilstra JS, John S, Gordon RA, et al. B cell-intrinsic TLR9 expression is protective in murine lupus. J Clin Invest. 2020;130(6):3172–3187. doi:10.1172/JCI132328
   PubMed Web of Science ®Google Scholar
• Fillatreau S, Manfroi B, Dörner T. Toll-like receptor signalling in B cells during systemic lupus erythematosus. Nat Rev Rheumatol. 2021;17(2):98–108. doi:10.1038/s41584-020-00544-4
   PubMed Web of Science ®Google Scholar
• Suurmond J, Diamond B. Autoantibodies in systemic autoimmune diseases: specificity and pathogenicity. J Clin Invest. 2015;125(6):2194–2202. doi:10.1172/JCI78084
   PubMed Web of Science ®Google Scholar
• Jackson SW, Scharping NE, Kolhatkar NS, et al. Opposing impact of B cell-intrinsic TLR7 and TLR9 signals on autoantibody repertoire and systemic inflammation. J Immunol. 2014;192(10):4525–4532. doi:10.4049/jimmunol.1400098
   PubMed Web of Science ®Google Scholar
• Petri M, Orbai AM, Alarcón GS, et al. Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64(8):2677–2686. doi:10.1002/art.34473
   PubMed Web of Science ®Google Scholar
• Gladman DD, Ibañez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002;29(2):288–291.
   PubMed Web of Science ®Google Scholar
• Yan WH, Lin A, Li M, Xu HH, Zhang ZP, Wang XX. Analysis of the 14 bp insertion and deletion polymorphism in human leukocyte antigen-G gene in two Chinese ethnic populations. Tissue Antigens. 2008;71(3):227–233. doi:10.1111/j.1399-0039.2008.01006.x
   PubMedGoogle Scholar
• Sestak AL, Fürnrohr BG, Harley JB, Merrill JT, Namjou B. The genetics of systemic lupus erythematosus and implications for targeted therapy. Ann Rheum Dis. 2011;70(Suppl 1):i37–43. doi:10.1136/ard.2010.138057
   PubMed Web of Science ®Google Scholar
• El Shahaway AA, Salah W, Shazly SA, Abd Elhady RR. Role of HLA-G 14 bp polymorphism and soluble HLA-G level in recurrent spontaneous abortion. Egypt J Med Microbiol. 2019;28:4.
   Google Scholar
• Farghaly WM, Saad Eldien HM, Sayed MA, et al. The relationship of HLA-G 14-bp insertion/deletion genetic polymorphism to the risk of multiple sclerosis and its clinical phenotypes. Egypt J Neurol Psychiatry Neurosurg. 2021;57(1):58. doi:10.1186/s41983-021-00312-5
   Google Scholar
• Tawfeek GA, Alhassanin S. HLA-G gene polymorphism in Egyptian patients with non-Hodgkin lymphoma and its clinical outcome. Immunol Invest. 2018;47(3):315–325. doi:10.1080/08820139.2018.1430826
   PubMed Web of Science ®Google Scholar
• Bae SC, Lee YH. Association of HLA-G polymorphisms with systemic lupus erythematosus and correlation between soluble HLA‑G levels and the disease: a meta-analysis. Z Rheumatol. 2021;80(1):96–102. doi:10.1007/s00393-020-00783-6
   PubMed Web of Science ®Google Scholar
• Lee YH, Bae SC. Association between a functional HLA-G 14-bp insertion/deletion polymorphism and susceptibility to autoimmune diseases: a meta-analysis. Cell Mol Biol. 2015;61(8):24–30.
   PubMed Web of Science ®Google Scholar
• Zhang X, Li S, Zhang Y, et al. Meta-analysis of the relationship between 14bp insertion/deletion polymorphism of HLA-G gene and susceptibility to systemic lupus erythematosus. Hum Immunol. 2014;75(12):1171–1176. doi:10.1016/j.humimm.2014.10.008
   PubMed Web of Science ®Google Scholar
• Wu FX, Wu LJ, Luo XY, et al. Lack of association between HLA-G 14-bp polymorphism and systemic lupus erythematosus in a Han Chinese population. Lupus. 2009;18(14):1259–1266. doi:10.1177/0961203309345756
   PubMed Web of Science ®Google Scholar
• Al-hasso IKQ, Al-Derzi AR, Abbas AA, Isho F, Alnuimi AS. The impact of the HLA-G 14 BP insertion/deletion polymorphism and soluble HLA-G serum level in systemic lupus erythematosus. Ann Trop Med Public Health. 2020;23(S12):SP231227. doi:10.36295/ASRO.2020.231227
   Google Scholar
• Farivar S, Shaabanpour Aghamaleki F. Effects of major epigenetic factors on systemic lupus erythematosus. Iran Biomed J. 2018;22(5):294–302. doi:10.29252/ibj.22.5.294
   PubMedGoogle Scholar
• Castelli E, Mendes-Junior C, Deghaide N, et al. The genetic structure of 3′untranslated region of the HLA-G gene: polymorphisms and haplotypes. Genes Immun. 2010;11(2):134–141. doi:10.1038/gene.2009.74
   PubMed Web of Science ®Google Scholar
• El-Haj IM, Ismail AM, El-Halafawy KE, Mortada WI, El-Sherbiny SM. Molecular analysis of HLA-DRB1 allelic associations with systemic lupus erythematous and lupus nephritis in Egyptians. Int J Adv Res. 2014;2(7):831–838.
   Google Scholar
• Bertolini M, McElwee K, Gilhar A, Bulfone-Paus S, Paus R. Hair follicle immune privilege and its collapse in alopecia areata. Exp Dermatol. 2020;29(8):703–725. doi:10.1111/exd.14155
   PubMed Web of Science ®Google Scholar
• Foschi V, Bortolotti D, Doyle AF, et al. Analysis of HLA-G expression in renal tissue in lupus nephritis: a pilot study. Lupus. 2019;28(9):1091–1100. doi:10.1177/0961203319860582
   PubMed Web of Science ®Google Scholar
• Cavalcanti A, Almeida R, Mesquita Z, Duarte ALBP, Donadi EA, Lucena-Silva N. Gene polymorphism and HLA-G expression in patients with childhood-onset systemic lupus erythematosus: a pilot study. HLA. 2017;90(4):219–227. doi:10.1111/tan.13084
   PubMed Web of Science ®Google Scholar
• Veit TD, Cordero EA, Mucenic T, et al. Association of the HLA-G 14 bp polymorphism with systemic lupus erythematosus. Lupus. 2009;18(5):424–430. doi:10.1177/0961203308098187
   PubMed Web of Science ®Google Scholar
• Consiglio CR, Veit TD, Monticielo OA, et al. Association of the HLA-G gene +3142C>G polymorphism with systemic lupus erythematosus. Tissue Antigens. 2011;77(6):540–545. doi:10.1111/j.1399-0039.2011.01635.x
   PubMedGoogle Scholar
• Mu R, Sun XY, Lim LT, et al. Toll-like receptor 9 is correlated to disease activity in Chinese systemic lupus erythematosus population. Chin Med J. 2012;125(16):2873–2877.
   PubMed Web of Science ®Google Scholar
• Li XL, Zhang Z, Zhang H. Expression level of TLR9, but not hypomethylation, is correlated with SLE disease activity. Physiol Res. 2019;68(6):973–980. doi:10.33549/physiolres.934167
   PubMed Web of Science ®Google Scholar
• Soni C, Reizis B. Self-DNA at the epicenter of SLE: immunogenic forms, regulation, and effects. Front Immunol. 2019;10:1601. doi:10.3389/fimmu.2019.01601
   PubMed Web of Science ®Google Scholar
• Shahin RMH, El Khateeb E, Khalifa RH, El Refai RM. Contribution of Toll-Like receptor 9 gene single-nucleotide polymorphism to systemic lupus erythematosus in Egyptian patients. Immunol Invest. 2016;45(3):235–242. doi:10.3109/08820139.2015.1137934
   PubMed Web of Science ®Google Scholar
• Dema B, Charles N. Autoantibodies in SLE: specificities, isotypes and receptors. Antibodies. 2016;5(1):2. doi:10.3390/antib5010002
   Web of Science ®Google Scholar
• Mortezagholi S, Babaloo Z, Rahimzadeh P, et al. Evaluation of TLR9 expression on PBMCs and CpG ODN-TLR9 ligation on IFN-α production in SLE patients. Immunopharmacol Immunotoxicol. 2017;39(1):11–18. doi:10.1080/08923973.2016.1263859
   PubMed Web of Science ®Google Scholar
• Ghaly NR, Kotb NA, Nagy HM, Rageh EM. Toll-like receptor 9 in systemic lupus erythematosus, impact on glucocorticoid treatment. J Dermatol Treat. 2013;24(6):411–417. doi:10.3109/09546634.2012.697110
   PubMed Web of Science ®Google Scholar
• Klonowska-Szymczyk A, Wolska A, Robak T, Cebula-Obrzut B, Smolewski P, Robak E. Expression of Toll-Like receptors 3, 7, and 9 in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Mediators Inflamm. 2014;2014:381418. doi:10.1155/2014/381418
   PubMed Web of Science ®Google Scholar
• Linnik MD, Hu JZ, Heilbrunn KR, Strand V, Hurley FL, Joh T. LJP 394 Investigator Consortium. Relationship between anti-double-stranded DNA antibodies and exacerbation of renal disease in patients with systemic lupus erythematosus. Arthritis Rheum. 2005;52(4):1129–1137. doi:10.1002/art.20980
   PubMed Web of Science ®Google Scholar
• Chauhan SK, Singh VV, Rai R, Rai M, Rai G. Distinct autoantibody profiles in systemic lupus erythematosus patients are selectively associated with TLR7 and TLR9 upregulation. J Clin Immunol. 2013;33(5):954–964. doi:10.1007/s10875-013-9887-0
   PubMed Web of Science ®Google Scholar
• Alegre E, Rizzo R, Bortolotti D, Fernandez-Landázuri S, Fainardi E, González A. Some basic aspects of HLA-G biology. J Immunol Res. 2014;2014:657625.
   PubMed Web of Science ®Google Scholar